Hodgkin's disease in children

Abstract

From 1921 to 1973, 106 children with Hodgkin's disease under the age of 17 years were seen at Roswell Park Memorial Institute and were analyzed retrospectively. Evaluation was separated into three eras: 1921-1949 (early era), 1950-1964 (middle era), and 1965-1973 (recent era). In the early era, suboptimal radiation therapy was employed. In the middle era, radiation therapy techniques were improved, and single-agent chemotherapy was introduced. In the recent era, multiagent chemotherapy routines were frequently used; aggressive external megavoltage radiation therapy became routine in conjunction with improvement in staging procedures. The best survival was observed in the recent era where five-year survival of 96% was noted in early stage disease. Favorable prognostic features included: younger age group (5-9 years), female sex, lymphocytic predominant histology, early stage disease, and complete response to therapy. Nodular sclerosing and mixed cell types had an equal prognosis. The concept of involved area radiotherapy along with combination chemotherapy appears a reasonable approach in children and should be tested in a randomized study against more extensive radiotherapy techniques in early stage disease.

Hodgkin's disease and non‐Hodgkin's lymphoma in children and young adults: A clinicopathologic study of 127 cases

“…The overall disease-free survival for all stages in our patients with Hodgkin's disease was 79%. This disease-free survival in our series is comparable with other pediatric series [12][13][14]21,22] and with adult series [23-251. The impressive improvement in survival for Hodgkin's disease over the past two decades is probably related to careful pathologic staging at diagnosis and to advances in chemotherapy treatment.…”